[Epigenetics' implication in autism spectrum disorders: A review]
- PMID: 27692350
- DOI: 10.1016/j.encep.2016.07.007
[Epigenetics' implication in autism spectrum disorders: A review]
Abstract
Background: The etiology of autism spectrum disorders (ASD) is complex and multifactorial, and the roles of genetic and environmental factors in its emergence have been well documented. Current research tends to indicate that these two factors act in a synergistic manner. The processes underlying this interaction are still poorly known, but epigenetic modifications could be the mediator in the gene/environment interface. The epigenetic mechanisms have been implicated in susceptibility to stress and also in the pathogenesis of psychiatric disorders including depression and schizophrenia. Currently, several studies focus on the consideration of the etiological role of epigenetic regulation in ASD.
Object: The object of this review is to present a summary of current knowledge of an epigenetic hypothesis in ASD, outlining the recent findings in this field.
Methods: Using Pubmed, we did a systematic review of the literature researching words such as: autism spectrum disorders, epigenetics, DNA methylation and histone modification.
Results: Epigenetic refers to the molecular process modulating gene expression without changes in the DNA sequence. The most studied epigenetic mechanisms are those that alter the chromatin structure including DNA methylation of cytosine residues in CpG dinucleotides and post-translational histone modifications. In ASD several arguments support the epigenetic hypothesis. In fact, there is a frequent association between ASD and genetic diseases whose epigenetic etiologies are recognized. A disturbance in the expression of genes involved in the epigenetic regulation has also been described in this disorder. Some studies have demonstrated changes in the DNA methylation of several autism candidate genes including the gene encoding the oxytocin receptor (OXTR), the RELN and the SHANK3 genes. Beyond the analysis of candidate genes, recent epigenome-wide association studies have investigated the methylation level of several other genes and showed hypomethylation of the whole DNA in brain and blood samples of autistic patients. The changes in epigenetic marks following exposure to environmental factors known as autism risk factors are also discussed in many reports. They include nutritional (vitamin D and folate) and toxic (sodium valproate, bisphenol A) factors. Despite a considerable contribution to understanding the complexity of ASD etiology, the epigenetic studies suffer from numerous methodological biases that limit the scope of their results and make their interpretation difficult. The cell samples used in the psychiatric studies are mostly from the post-mortem tissue of the central nervous system, and factors that might change the epigenome (age, gender, treatments received…) are not taken into account. The use of blood and buccal epithelium samples raises in turn the question as to whether the epigenome of these cells reflects that of the nerve cells. DNA methylation can also be influenced by cell subcomposition variability, transcriptional variability and by DNA sequence variants.
Conclusion: These recent discoveries in epigenetics are the beginnings of an etiopathogenic research revolution in neurodevelopmental disorders. The conceptualization of epigenetic processes is in its early stages and despite its limited means will help integrate disparate data factors previously involved in autism. It could also be the target for the development of new therapeutic modalities.
Keywords: Autism spectrum disorders; DNA methylation; Epigenetics; Histone; Méthylation ADN; Troubles du spectre autistique; Épigénétique.
Copyright © 2016 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
[Epigenetics of schizophrenia: a review].Encephale. 2014 Oct;40(5):380-6. doi: 10.1016/j.encep.2014.06.005. Epub 2014 Aug 12. Encephale. 2014. PMID: 25127897 Review. French.
-
Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants.Clin Epigenetics. 2019 Jul 16;11(1):103. doi: 10.1186/s13148-019-0684-3. Clin Epigenetics. 2019. PMID: 31311581 Free PMC article.
-
Epigenomics in stress tolerance of plants under the climate change.Mol Biol Rep. 2023 Jul;50(7):6201-6216. doi: 10.1007/s11033-023-08539-6. Epub 2023 Jun 9. Mol Biol Rep. 2023. PMID: 37294468 Review.
-
Epigenetics of Autism Spectrum Disorder.Adv Exp Med Biol. 2017;978:63-90. doi: 10.1007/978-3-319-53889-1_4. Adv Exp Med Biol. 2017. PMID: 28523541 Review.
-
DNA Methylation Associated with Mitochondrial Dysfunction in a South African Autism Spectrum Disorder Cohort.Autism Res. 2020 Jul;13(7):1079-1093. doi: 10.1002/aur.2310. Epub 2020 Jun 3. Autism Res. 2020. PMID: 32490597 Free PMC article.
Cited by
-
Clustering Analysis Supports the Detection of Biological Processes Related to Autism Spectrum Disorder.Genes (Basel). 2020 Dec 9;11(12):1476. doi: 10.3390/genes11121476. Genes (Basel). 2020. PMID: 33316975 Free PMC article.
-
Paving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder.Oxid Med Cell Longev. 2021 Aug 21;2021:1131280. doi: 10.1155/2021/1131280. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34471461 Free PMC article.
-
Maternal Nutrition and Neurodevelopment: A Scoping Review.Nutrients. 2021 Oct 8;13(10):3530. doi: 10.3390/nu13103530. Nutrients. 2021. PMID: 34684531 Free PMC article.
-
Prenatal Nutritional Factors and Neurodevelopmental Disorders: A Narrative Review.Life (Basel). 2024 Aug 29;14(9):1084. doi: 10.3390/life14091084. Life (Basel). 2024. PMID: 39337868 Free PMC article. Review.
-
Particulate matter exposure shapes DNA methylation through the lifespan.Clin Epigenetics. 2019 Aug 30;11(1):129. doi: 10.1186/s13148-019-0726-x. Clin Epigenetics. 2019. PMID: 31470889 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous